Skip to content

Clinical trials

Retinal Degeneration trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Country / region: Canada Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20151
20161
20191
20213
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting4
Completed2
Terminated2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
4D Molecular Therapeutics1
AbbVie1
Beacon Therapeutics1
Elisigen, Inc.1
Jaeb Center for Health Research1
NightstaRx Ltd, a Biogen Company1
Novartis Pharmaceuticals1
OccuLogix1
Opthea Limited1
ProQR Therapeutics1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration10
Eye Diseases5
Macular Degeneration5
Retinal Diseases5
Wet Macular Degeneration4
Choroidal Neovascularization3
Choroideremia2
Retinal Dystrophies2
Vision Disorders2
Blindness1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.